Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Huida Biotech is a high-tech enterprise specializing in the application of synthetic biology and enzymatic catalysis for the production of high-value pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company leverages a proprietary library of engineered enzymes to replace traditional chemical synthesis with greener, more efficient biological processes. Their core business includes the development and manufacturing of chiral intermediates, unnatural amino acids, and nucleoside analogs. Huida Biotech provides both catalog products and custom synthesis services (CRO/CDMO) to global pharmaceutical and biotechnology partners, focusing on cost reduction and environmental sustainability in drug manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Huida Biotech.